CUSIP: 67092P888
Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / NUVEEN ESG EMRGN
-
Total 13F shares
-
7,136,317
-
Share change
-
-657,279
-
Total reported value
-
$237,016,372
-
Price per share
-
$33.21
-
Number of holders
-
108
-
Value change
-
-$21,790,411
-
Number of buys
-
43
-
Number of sells
-
43
Security key
67092P888
Report period
Q2 2025
Institutions
108
Top holders
10
Reporting periods
Holder history for CUSIP 67092P888
Recent filing periods:
Top shareholders of NUEM - NUSHARES ETF TR - NUVEEN ESG EMRGN (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of NUSHARES ETF TR - NUVEEN ESG EMRGN (NUEM) as of Q2 2025
As of 30 Jun 2025,
NUSHARES ETF TR - NUVEEN ESG EMRGN (NUEM) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,136,317 shares.
The largest 10 holders included
TIAA TRUST, NATIONAL ASSOCIATION, Wealthfront Advisers LLC, Abacus Wealth Partners, LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, TFC Financial Management, Inc., Colorado Capital Management, Inc., UBS Group AG, Cambridge Investment Research Advisors, Inc., and Vestmark Advisory Solutions, Inc..
This page lists
108
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor |
Q1 2025 Shares |
Q2 2025 Shares |
Share Diff |
Share Chg % |
Q1 2025 Value $ |
Q2 2025 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.